Earth Science Tech (ETST) Cost of Revenue (2011 - 2026)
Earth Science Tech's (ETST) quarterly Cost of Revenue came in at $2.8 million in Q2 2026, up 3.04% on a YoY basis from $2.7 million in Q2 2025, and down 14.68% quarter-over-quarter from $3.2 million in Q1 2026.
Analysis
Earth Science Tech (ETST) Cost of Revenue (2011 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Cost of Revenue for 15 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cost of Revenue rose 3.04% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2026 stood at $10.3 million (up 10.29% YoY), and the FY2026 full-year result was $10.2 million, up 15.76% from the prior year.
- Cost of Revenue slipped to $2.8 million in Q2 2026 per ETST's latest filing, from $3.2 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $3.2 million in Q1 2026 and bottomed at $4200.0 in Q4 2022.
- Historically, Cost of Revenue has averaged $1.6 million across 5 years, with a median of $2.1 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue plunged 36.35% in 2022, then surged 33552.71% in 2023.
- Over 5 years, Cost of Revenue stood at $4200.0 in 2022, then soared by 33552.71% to $1.4 million in 2023, then soared by 60.3% to $2.3 million in 2024, then fell by 12.27% to $2.0 million in 2025, then surged by 38.37% to $2.8 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $2.8 million, $3.2 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 1.99 Bn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | 2.30 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 455.94 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 461.69 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 753.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 52.20 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 100.16 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 90.43 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 721,000.00 |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 2.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.75 Mn |
| Mar 31, 2026 | 3.22 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 746,226.00 |
| Jun 30, 2023 | 71,165.00 |
| Mar 31, 2023 | 22,277.00 |
| Dec 31, 2022 | 4,200.00 |
| Mar 31, 2022 | 15,095.00 |
| Dec 31, 2021 | 2,467.00 |
| Sep 30, 2021 | 1,332.00 |
| Jun 30, 2021 | 3,745.00 |
| Mar 31, 2021 | 23,714.00 |